Related references
Note: Only part of the references are listed.NDI-010976, A POTENT, LIVER-DIRECTED, ORAL INHIBITOR OF ACETYL COA CARBOXYLASE FOR NON-ALCOHOLIC STEATOHEPATITIS: A PHASE 1 SINGLE ASCENDING DOSE STUDY IN HEALTHY VOLUNTEERS
W. F. Westlin et al.
JOURNAL OF HEPATOLOGY (2016)
Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats
Geraldine Harriman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Increased De Novo Lipogenesis Is a Distinct Characteristic of Individuals With Nonalcoholic Fatty Liver Disease
Jennifer E. Lambert et al.
GASTROENTEROLOGY (2014)
Decreasing the Rate of Metabolic Ketone Reduction in the Discovery of a Clinical Acetyl-CoA Carboxylase Inhibitor for the Treatment of Diabetes
David A. Griffith et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Non-alcoholic fatty liver disease: a practical approach to diagnosis and staging
Jessica K. Dyson et al.
FRONTLINE GASTROENTEROLOGY (2014)
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin
Morgan D. Fullerton et al.
NATURE MEDICINE (2013)
Cynomolgus Monkey as a Potential Model to Assess Drug Interactions Involving Hepatic Organic Anion Transporting Polypeptides: In Vitro, In Vivo, and In Vitro-to-In Vivo Extrapolation
Hong Shen et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans
Ksenia Sevastianova et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)
Soraphen A, an inhibitor of acetyl CoA carboxylase activity, interferes with fatty acid elongation
Donald B. Jump et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Synthesis of specific fatty acids contributes to VLDL-triacylglycerol composition in humans with and without type 2 diabetes
M. S. Wilke et al.
DIABETOLOGIA (2009)
Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease
Elisa Fabbrini et al.
GASTROENTEROLOGY (2008)
A pilot study of the effects of pioglitazone and rosiglitazone on de novo lipogenesis in type 2 diabetes
Carine Beysen et al.
JOURNAL OF LIPID RESEARCH (2008)
Role of the murine organic anion-transporting polypeptide 1b2 (Oatp1b2) in drug disposition and hepatotoxicity
Raymond Evers et al.
MOLECULAR PHARMACOLOGY (2008)
Acetyl-coenzyme A carboxylases: Versatile targets for drug discovery
Liang Tong et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans
Aruna Vedala et al.
JOURNAL OF LIPID RESEARCH (2006)
Expression profiles of 50 xenobiotic transporter genes in humans and pre-clinical species: A resource for investigations into drug disposition
K. Bleasby et al.
XENOBIOTICA (2006)
Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells
Yuren Wei et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)
Treating the metabolic syndrome: acetyl-CoA carboxylase inhibition
HJ Harwood
EXPERT OPINION ON THERAPEUTIC TARGETS (2005)
Isozyme-nonselective N-substituted bipiperidylcarboxamide acetyl-CoA carboxylase inhibitors reduce tissue malonyl-CoA concentrations, inhibit fatty acid synthesis, and increase fatty acid oxidation in cultured cells and in experimental animals
HJ Harwood et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Triglyceride accumulation protects against fatty acid-induced lipotoxicity
LL Listenberger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Dysregulation of fatty acid metabolism in the etiology of type 2 diabetes
JD McGarry
DIABETES (2002)
Share Paper
